These new codes are required to access Medicare/Medicaid insurance reimbursement for novel CELLSEARCH Circulating Multiple Myeloma Cell (CMMC) and HER2 Circulating Tumor Cell (CTC-HER2) assays
- These new Codes are required to access Medicare/Medicaid insurance Reimbursement for novel CELLSEARCH Circulating Multiple Myeloma Cell (CMMC) and HER2 .
/PRNewswire/ Immunovia AB (NASDAQ Stockholm: IMMNOV) announced, that Immunovia, Inc., its American subsidiary, has recently received approval for a Current.